Abstract
Chimeric peptides are unnatural constructs consisting of bioactive compounds from at least two different peptide(s) and/or protein(s) or two sequences from differentparts of the same protein. Such multifunctional peptide combinations are prepared to enhance the biological activity or selectivity of their components. New biological effects can also be achieved with the chimera. In this chapter the synthesis of three different types of chimeric peptides will be described. In a linear chimera, two peptide epitopes from different parts of glycoprotein D (gD) of herpes simplex virus (HSV) are combined. A branched chimera, built from linear peptides, consists of tuftsin oligomers with immunostimulatory activity and an epitope peptide of HSV gD. The third compound is a cyclic chimeric molecule, where α-conotoxinGI as a host peptide is modified by the incorporation of a core epitope from HSV gD as a guest sequence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Foran, S. E., Carr, D. B., Lipkowski, A. W., et al. (2000) A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic. Proc. Natl. Acad. Sci. USA 97, 7621–7626.
Vella, F., Hernandez, J.-F., Molla, A., Block, M. R., and Arlaud, G. J. (1999) Grafting an RGD motif onto an epidermal growth factor-like module: chemical synthesis and functional characterization of the chimeric molecule. J. Pept. Res. 54, 415–426.
Gilbert, M., Shaw, W. J., Long, J. R., et al. (2000) Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J. Biol. Chem. 275, 16213–16218.
Gil-Parrado, S., Assfalg-Machleidt, I., Fiorino, F., et al. (2003) Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation of with penetratin. Biol. Chem. 384, 395–402.
Rusnati, M., Urbinati, C., Musulin, B., et al. (2001) Activation of endothelia cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium 8, 65–74.
Ruzza, P., Donella-Deana, A., Calderan, A., et al. (2001) Antennapedia/HS1 chimeric phosphotyrosyl peptide: Conformational properties, binding capability to c-Fgr SH2 domain and cell permeability. Biopolymers 60, 290–306.
Magzoub, M., Kilk, K., Eriksson, L, E., Langel, , and Graslund, A. (2001) Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles. Biochim. Biophys. Acta 1512, 77–89.
Gomme, P. T., Thompson, P. E., Whisstock, J., Stanton, P. G., and Hearn, M. T. W. (1999) Characterization of epitope regions of thyrotropin b-subunit recognized by the monoclonal antibodies mAb279 and mAb299: a chimeric peptide approach. J. Pept. Res. 54, 218–229.
Hel, Z., Johnson, L. M., Tryniszewska, E., et al. (2002) A novel chimeric Rev, tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine. Vaccine 20, 3171–3186.
Louis, J. M., Bewley, C. A., and Clore, G. M. (2001) Design and properties of NCCG-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity. J. Biol. Chem. 276, 29,485–29,489.
Misicka, A., Lipkowski, A. W., Horvath, R., et al. (1994) Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoues. Int. J. Pept. Prot. Res. 44, 80–84.
Mezö, G., Drakopoulou, E., Paál, V., Rajnavölgyi, É., Vita, C., and Hudecz, F. (2000) Synthesis and immunological studies of α-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein. J. Pept. Res. 55, 7–17.
Drakopoulou, E., Uray, K., Mezö, G., Price, M. R., Vita, C., and Hudecz, F. (2000) Synthesis and antibody recognition of mucin 1 (MUC-l)-α-conotoxin chimera. J. Pept. Sci. 6, 175–185.
Hackeng, T. M., Rosing, J., Spronk, H. M. H., and Vermeer, C. (2001) Total chemical synthesis of human matrix Gla protein. Protein Science 10, 864–870.
Mezö, G., de Oliveira E., Krikorian D., et al. (2003) Synthesis and comparision of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjug. Chem. 11, 1260–1269.
Stewart, J. M. and Young, J. D. (1984) Solid Phase Peptide Synthesis 2nd ed., Pierce Chemical Co., Rockford, IL.
Grant, G. A., ed. (1992) Synthetic Peptides. A User%s Guide. W. H. Freeman and Company, New York.
Lloyd-Williams, P., Albericio, F., and Giralt, E. (1993) Convergent solid-phase peptide synthesis. Tetrahedron 49, 11,065–11,133.
Andreu, D., Albericio, F., Sol, N. A., Munson, M. C., Ferrer, M., andBarany, G. (1994) Disulfide bond formation. Methods Mol. Biol. 35, 91–169.
Robey, F. A. and Fields, R. L. (1989) Automated synthesis of bromoacetyl-modified peptides for preparation of synthetic peptide polymers, peptide-protein conjugates and cyclic peptides. Anal. Biochem. 177, 373–377.
Dawson, P. E. and Kent, S. B. H. (2000) Synthesis of native proteins by chemical ligation. Ann. Rev. Biochem. 69, 925–962.
Welling-Wester, S., Scheffer, A.-J., and Welling, G. W. (1991) B and T cell epitopes of glycoprotein D of herpes simplex virus type 1. Microbial. Immunol. 76, 59–68.
Welling-Wester, S., Feijbrief, M., Koedijk, D. G., et al. (1994) Anologues of peptide 9-21 of glycoprotein D of Herpes simplex virus and their binding to group VII monoclonal antibodies. Arch. Virol. 138, 331–340.
Isola, V. J., Eisenberg, R. J., Siebert, G. H., Heilmanm, C. J., Wicox, W. C., and Cohen, G. H. (1989) Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J. Virol. 63, 2325–2334.
Weijer, W. J., Drijfhout, J. W., Geerlings, H. J., et al. (1988) Antibodies against synthetic peptides of herpse simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J. Virol. 62, 501–510.
Kaiser, E., Colescott, C. D., Bossinger, C. D., and Cook, P. I. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595–598.
Krchnak, V., Vagner, J., Safar, P., and Lebl, M. (1988) Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Collect. Czech. Chem. Commun. 53, 2542–2548.
Fridkin, M. and Najjar, V. A. (1989) Tuftsin: its chemistry, biology, and clinical potential. Crit. Rev. Biochem. Mol. Biol. 24, 1–40.
Siemion, I. Z. and Kluczyk, A. (1999) Tuftsin: On the 30-year anniversary of Victor Najjar%s discovery. Peptides 20, 645–674.
Trudelle, Y., Brack, A., Delmas, A., Pedoussaut, S., and Rivaille, P. (1987) Synthesis of a new carrier for immunization: polytuftsin. Two examples of its use with peptides selected in the hepatitis B surface antigen. Int. J. Pept. Prot. Res. 30, 54–60.
Gokulan, K., Khare, S., and Rao, D. N. (1999) Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40). DNA Cell Biol. 18, 623–630.
Mezö, G., Kalászi, A., Reményi, J., et al. (2004) Synthesis conformation and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence. Bio-polymers 73, 645–656.
Ivanov, B. B. and Robey, F. A. (1996) Effective use of free thiols as scavangers for HF coctails to deprotect bromo-and chloroacetylated synthetic peptides. Pept. Res. 9, 305–307.
Kobayashi, Y., Ohkubo, T., Kyogoku, Y., Sakakibara, S., Braun, W., and Go, N. (1989) Solution conformation of conotoxin GI determined by 1H nuclear magnetic resonans spectroscopy and distance geometry calculations. Biochemistry 28, 4853–4860.
Hudecz, F., Hilbert, ., Mezö, G., et al. (1993) Epitope mapping of the 273-284 region of HSV glycoprotein D by synthetic branched polypeptide-carrier conju-gates. Pept. Res. 6, 263–271.
Adamson, J. G. and Lajoie, G. A. (1994) Guanidine hydrochloride assists intramolecular disulfide bond formation in cysteine peptides. In Peptides 1993 (Hodges, R. S. and Smith, J. A., eds.), ESCOM, Leiden, The Netherlands, pp. 44–45.
Ellman G. L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70–77.
Kamber B. (1971) Cystine peptides from (S-acetamidomethyl-cysteine)-peptides through oxidation with iodine: synthesis of cyclo-L-cystine. Helv. Chem. Acta 54, 927–930.
Tamamura H., Otaka A., Nakamura J., et al. (1993) Disulfide bond formation in S-acetamidomethyl cysteine-containing peptides by the combination of silver trifluoromethansulfonate and dimethylsulfoxide/aqueous HCl. Tetrahedron Lett. 34, 4931–4934.
Fujii N., Otaka A., Funakoshi S., Bessho K., and Yajima, H. (1987) Studies on peptides. CLI. Synthesis of cystine-peptides by oxidation of S-protected cysteinepeptides with thallium(III) trifluoroacetate. Chem. Pharm. Bull. 35, 2339–2347.
Landon M. (1977) Cleavage at aspartyl-prolyl bonds. Methods Enzymol. 47, 145–149.
Skribanek, Z., Mezö, G., Mák, M., and Hudecz, F. (2002) Mass spectrometric and chemical stability of the Asp-Pro bond in herpes simplex virus epitope peptides compared with X-Pro bonds of related sequences. J. Pept. Sci. 8, 398–406.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Mezö, G., Hudecz, F. (2005). Synthesis of Linear, Branched, and Cyclic Peptide Chimera. In: Howl, J. (eds) Peptide Synthesis and Applications. Methods in Molecular Biology™, vol 298. Humana Press. https://doi.org/10.1385/1-59259-877-3:063
Download citation
DOI: https://doi.org/10.1385/1-59259-877-3:063
Publisher Name: Humana Press
Print ISBN: 978-1-58829-317-6
Online ISBN: 978-1-59259-877-9
eBook Packages: Springer Protocols